Sagar Doshi

Okay. Sir, just wanted to ask, like, we have a good year -on-year growth. So, specific region of drivers for it. So, I don't want any guidance, but what's the sustainability of the revenue or the profit jump that we have this year? So, next year or, let's say, in the next two years, will we be at least able to maintain this rate or what would it be? That's the first one. Second is, how dependent are we on Rivlimed?

Okay. So, can you just tell me the percentage that Revlimid contributes as on today?

The revenue percentage that we generate from the Revlimid sales as on today?